Psychiatric and cardiovascular comorbidities in patients with diabetes mellitus starting antiobesity drugs

Obesity

Volumn 16, Issue 10, 2008, Pages 2331-2335

  Willemen, Marjolein J ^a,b   Mantel Teeuwisse, Aukje K ^a,b   Straus, Sabine M ^b   Leufkens, Hubert G ^a,b   Egberts, Antoine C ^a,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b MEDICINES EVALUATION BOARD   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT;

ADULT; AGE; AGED; ANXIETY; ARTICLE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; FEMALE; HUMAN; MALE; MEDICAL RECORD; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDY; RISK; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; UNITED KINGDOM;

ADULT; AGE FACTORS; AGED; ANTI-OBESITY AGENTS; ANXIETY; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; FEMALE; GREAT BRITAIN; HUMANS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; OBESITY; ODDS RATIO; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 53849148222     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.362     Document Type: Article

References (11)

1. Summary Minutes of the Endocrinologic and Metabolic Drugs Advisory Committee meeting: Food and Drug Administration; 23 June 2007.
2. Wood L, Martinez C. The general practice research database: role in pharmacovigilance. Drug Saf 2004;27:871-881.
3. Jick SS, Kaye JA, Vasilakis-Scaramozza C et al. Validity of the general practice research database. Pharmacotherapy 2003;23:686-689.
4. Lawrenson R, Williams T, Farmer R. Clinical information for research; the use of general practice databases. J Public Health Med 1999;21:299-304.
5. Verdel BM, Souverein PC, Egberts AC, Leufkens HG. Difference in risks of allergic reaction to sulfonamide drugs based on chemical structure. Ann Pharmacother 2006;40:1040-1046.
6. van de Garde EM, Hak E, Souverein PC et al. Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax 2006;61:957-961.
7. Prince M, Patel V, Saxena S et al. No health without mental health. Lancet 2007;370:859-877.
8. Ioannides-Demos LL, Proietto J, Tonkin AM, McNeil JJ. Safety of drug therapies used for weight loss and treatment of obesity. Drug Saf 2006;29:277-302.
9. Abenhaim L, Moride Y, Brenot F et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 1996;335:609-616.
10. Jick H, Vasilakis C, Weinrauch LA et al. A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation. N Engl J Med 1998;339:719-724.
11. Obesity: weight loss without drugs: a balanced diet avoiding high-calorie foods, plus exercise. Prescrire Int 2007;16:162-167.